Search – Indianapolis Business Journal

Home » Search

Articles

UPDATE: Eli Lilly acquiring Boston-based biotech in deal worth up to $7B

April 20, 2026 | IBJ Staff

Lilly has been bringing in record revenue from its weight-loss medicines, but continues to diversify its pipeline candidates through acquisitions of biotech companies that are developing new genetic therapies for cancer and other disorders.

Braun administration, Eli Lilly to collaborate on nuclear power development

April 16, 2026 | Joey Harris

The Indianapolis-based pharmaceutical giant and the state’s Office of Energy Development signed a nonbinding letter of intent to explore the potential deployment of small modular reactors.

Eli Lilly weight-loss pill Foundayo now available in United States

April 9, 2026 | Daniel Bradley

The Indianapolis-based drugmaker has started shipping the new pill to retail pharmacies.

FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity

April 1, 2026 | Associated Press

The daily oral medication, which will be branded as Foundayo, is expected to begin shipping Monday.

Eli Lilly begins using ‘mind-blowing’ LillyPod supercomputer at Indy campus

February 25, 2026 | Daniel Bradley

LillyPod, which occupies 30,000 square feet in a room the size of a football field, is capable of crunching massive amounts of data at high speeds and is expected to help the Lilly discover and develop drugs at a faster pace.

Eli Lilly set to back Aktis Oncology’s upsized $318M IPO

January 7, 2026 | Bloomberg News

Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.

UPDATE: Eli Lilly stock reaches new high, tops $1,000-per-share mark

November 12, 2025 | IBJ Staff

Lilly’s shares have taken off in the wake of several significant deals and after it received fast-track regulatory review for highly anticipated weight-loss pill orforglipron.

Eli Lilly to build $3B manufacturing site in Netherlands

November 3, 2025 | Daniel Lee

The facility is expected to produce oral medications, including Lilly’s highly anticipated GLP-1 pill for weight loss, orforglipron.

Eli Lilly plans to make highly anticipated weight-loss pill at new $6.5B Texas plant

September 23, 2025 | Daniel Lee

The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.

Eli Lilly to build $5B plant in Virginia—first of 4 U.S. sites to be named this year

September 16, 2025 | Daniel Lee

Indianapolis-based Lilly said the new plant would create more than 650 jobs in Virginia for engineers, scientists, operations personnel and lab technicians, as well as 1,800 construction jobs.

Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

August 12, 2025 | Daniel Lee

The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe Lilly medications including Zepbound and Mounjaro.

3 ways GLP-1 drugs could be getting better

June 11, 2026 | The Washington Post

A race is shaping up among drug manufacturers that are vying to roll out better options when it comes to weight-loss drugs.

Lilly’s 30% weight loss sets high bar for obesity drug race

June 8, 2026 | Bloomberg News

At the American Diabetes Association meeting in New Orleans, market leader Eli Lilly and Co. asserted its dominance in the weight-loss market.

Citizens Energy reaches agreements on multiple eminent domain cases for LEAP-related project

June 5, 2026 | Joey Harris

If fulfilled, the proposed agreements signal an end for some potential legal roadblocks to the development of the Citizens-Lebanon Water Supply Program.

Work begins on Butler entertainment venue tailored to students

June 4, 2026 | Dave Lindquist

The Allen Whitehill Clowes Ballroom is being built adjacent to Clowes Memorial Hall and the Schrott Center for the Arts.

The science involving GLP-1 drugs and cancer is getting much more interesting

June 4, 2026 | The Washington Post

After transforming the treatment of diabetes and weight loss, a growing body of research is raising the possibility that these drugs may help protect against cancer.

Wally’s set to open in Whitestown this month

June 4, 2026 | Elissa Maudlin

The travel center will feature a convenience store, gift shop, extensive food offerings and bathrooms, plus gas pumps and electric vehicle charging stations.

Lilly: Drug shows promise against early lung cancer with rare biomarker

June 3, 2026 | Daniel Bradley

Trial patients who received the drug after surgery or radiation therapy experienced an 83% reduction in the risk of disease recurrence or death compared with those who received a placebo.

Indianapolis-based Fathers and Families Center announces $5.5M campaign, new location